No Data
No Data
Nomura Downgrades Vipshop(VIPS.US) to Hold Rating, Cuts Target Price to $14
Nomura analyst Jialong Shi downgrades $Vipshop(VIPS.US)$ to a hold rating, and adjusts the target price from $21 to $14.According to TipRanks data, the analyst has a success rate of 46.2% and a total
Nomura Downgrades Vipshop Holdings to Neutral From Buy, Cuts Price Target to $14 From $21
06:52 AM EDT, 06/28/2024 (MT Newswires) -- Nomura Downgrades Vipshop Holdings to Neutral From Buy, Cuts Price Target to $14 From $21 Price: 13.23, Change: +0.08, Percent Change: +0.61
Nomura downgraded vipshop (VIPS.US) to "neutral" with a target price of $14 amid intensified competition and worsening e-commerce ecology in the book "Da Hang".
Nomura released a report lowering the investment rating of VIPS.US from "Buy" to "Neutral" and lowering the target price from $21 to $14. The report states that Vipshop needs to make difficult choices between maintaining stable profit margins and revenue growth. The report also mentioned that the intensified competition among e-commerce giants has worsened the business environment, and the price competition in the e-commerce industry has never been so intense. PDD.US originally launched a low stock price strategy, which was imitated by Alibaba-SW (09988.HK) (BABA.US) and JD.com-SW (09618.HK) (JD.US). Alibaba and JD.com both
Asian Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
Asian equities traded in the US as American depositary receipts were flat in late Thursday morning trading, nudging 0.04% higher to 1,957.15 on the S&P Asia 50 ADR Index. From North Asia, the gainers
Express News | Vipshop Holdings Ltd : Jefferies Cuts Target Price to $20.3 From $20.8
Futu Morning News | Nvidia returns to the $3 trillion club! Receives support from famous investors; rate cut in sight? Fed Governor Lael Brainard: inflation control is now in sight
BNP Paribas: With the approaching of the Fed's interest rate cut, the S&P 500 index will maintain a "buy on dips" mode; Rivian receives a $500 million investment from Volkswagen in Germany, and the stock price soars more than 50% after hours; Novo Nordisk's semaglutide for obesity treatment has been approved in China, and the stock price hits a new record high again.